Earnings Feed
Start Free
AMN HEALTHCARE SERVICES INC·4/A

Jan 30, 10:51 AM ET

Laughlin Whitney M 4/A

4/A · AMN HEALTHCARE SERVICES INC · Filed Jan 30, 2026

Research Summary

AI-generated summary of this filing

Updated

AMN (AMN) CLO Whitney M. Laughlin Receives 19,641 RSU Award

What Happened

  • Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare (AMN), had RSUs vest and received a new RSU grant on Jan 15, 2026. A total of 4,488 vested RSUs converted into common shares (no exercise price). Of those, 1,332 shares were withheld/sold to cover tax obligations at $19.55 per share, generating $26,041. Net delivered shares from the vesting were 3,156.
  • Separately, Laughlin was granted 19,641 new Restricted Stock Units (RSUs) on Jan 15, 2026 (these are derivative awards that vest over time). This filing is an amendment to correct previously overstated beneficial ownership.

Key Details

  • Transaction date: January 15, 2026. Tax-withheld shares sold at $19.55/share (total proceeds $26,041).
  • Vesting/conversion: 4,488 RSUs converted to common stock (no cash exercise price). Tax withholding: 1,332 shares withheld.
  • New grant: 19,641 RSUs awarded (vest in three tranches over the next 1–3 years per plan terms).
  • Shares owned after transaction: Amended Form 4 reports 19,641 securities beneficially owned by the reporting person (corrects prior report that overstated ownership as 39,282).
  • Notable footnotes: F1/F2 explain RSU vesting and share withholding for taxes; F9 describes the Jan 15, 2026 RSU grant vesting schedule; F10 explains this is an AMENDED filing to correct the previously reported ownership number.
  • Filing: Amended Form 4 filed Jan 30, 2026 to correct prior reporting error (original Form 4 filed Jan 16, 2026 had overstated derivative holdings).

Context

  • These transactions are compensation-related (RSU vesting and a new RSU award), not open-market purchases — vesting conversions have $0 exercise price and are routine for executive compensation.
  • The company withheld/sold shares to cover taxes (common practice); this is not necessarily a cash sale by the insider expressing a view on the stock.
  • The amended filing merely corrects the post-transaction beneficial ownership figure and does not indicate additional trading activity.

Insider Transaction Report

Form 4/AAmended
Period: 2026-01-15
AMN HEALTHCARE SERVICES INCAMN
Laughlin Whitney M
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+202→ 20,698 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh−60$1,173→ 20,638 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+749→ 21,387 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh−223$4,360→ 21,164 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-15+3,537→ 24,701 total
  • Tax Payment

    Common Stock

    [F2]
    2026-01-15$19.55/sh−1,049$20,508→ 23,652 total
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F4][F5]
    2026-01-15−202→ 0 total
    → Common Stock (202 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F6][F5]
    2026-01-15−749→ 772 total
    → Common Stock (749 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F3][F7][F5]
    2026-01-15−3,537→ 7,182 total
    → Common Stock (3,537 underlying)
  • Award

    Restricted Stock Units

    [F8][F9][F5][F10]
    2026-01-15+19,641→ 19,641 total
    → Common Stock (19,641 underlying)
Footnotes (10)
  • [F1]Common stock acquired on the vesting of Restricted Stock Units.
  • [F10]Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 19,641 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 19,641 securities were beneficially owned by reporting person, not 39,282 as previously reported.
  • [F2]Number of shares withheld for tax purposes.
  • [F3]The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
  • [F4]The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F5]Restricted Stock Units do not have an expiration date.
  • [F6]The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F7]The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
  • [F8]The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
  • [F9]The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.
Signature
/s/ Whitney M. Laughlin|2026-01-29

Documents

1 file
  • 4
    wk-form4a_1769788304.xml

    FORM 4/A